Cardiotoxicity Following Cancer Treatment

More than half of those born after 1960 will develop cancer during their lifetime. Fortunately, owing to improved diagnosis and treatment, cure rates have risen steadily over the last three decades. With an increased survivorship, more will experience adverse effects of cancer therapeutics on the he...

Full description

Saved in:
Bibliographic Details
Published inThe Ulster medical journal Vol. 86; no. 1; pp. 3 - 9
Main Authors Walls, G M, Lyon, A R, Harbinson, M T, Hanna, G G
Format Journal Article
LanguageEnglish
Published Northern Ireland The Ulster Medical Society 01.01.2017
Subjects
Antineoplastic Agents - adverse effects
Heart Diseases - etiology
Humans
Molecular Targeted Therapy - adverse effects
Neoplasms - therapy
Radiotherapy - adverse effects
Review
Online AccessGet full text

Cover

More Information
Summary:More than half of those born after 1960 will develop cancer during their lifetime. Fortunately, owing to improved diagnosis and treatment, cure rates have risen steadily over the last three decades. With an increased survivorship, more will experience adverse effects of cancer therapeutics on the heart. As the oncologist's focus begins to encompass the issues of cancer survivorship, awareness of the management of cardiac toxicity would be prudent for all physicians looking after patients with cancer.
ISSN:0041-6193
2046-4207